Logan's Story
Logan's Battle: ALK+ Anaplastic Large Cell Lymphoma
Logan Goodson, a young soul, faced the harsh reality of ALK+ Anaplastic Large Cell Lymphoma (ALCL), a subtype that often affects children and young adults. Despite initial positive responses to treatment, Logan's journey took a difficult turn when the disease resurged, ultimately invading his neurologic system.
​
A Glimpse of Hope: Alectinib Enters the Scene
Faced with limited options, Logan's oncologist at MD Anderson explored unconventional paths. Drawing inspiration from a study in Japan, Logan began a treatment regimen involving Alectinib, a drug primarily used for lung cancer. Miraculously, his neurologic symptoms improved, offering a glimpse of hope and a temporary respite from the relentless disease.
​
A Desperate Search for a Lifesaving Donor
As the battle continued, the need for a stem cell transplant became imminent. However, despite months of searching, a compatible donor remained elusive. Logan's fleeting joy and improved quality of life gave way to the heartbreaking reality of a return of the disease, this time in is cerebral spinal fluid, called leptomeningeal disease.
​
Logan's journey shines a light on the urgent need for advancements in T-cell lymphoma research
Logan's Wish
During Logan's worst days he made sure to tell his wife and doctor that we needed to find new treatments. Knowing that he could potentially save someone else from having to endure the pain and suffering he was experiencing would provide him peace. This is why we continue to raise money. Until a new therapy is approved. #ForeLogan
About Logan
Honoring a Legacy of Kindness, Passion, and Resilience
Welcome to the heart of our event, where we celebrate the life and spirit of Logan Goodson. Logan was not just a friend, a husband, a son, a dog dad, an uncle, and a colleague—he was the embodiment of kindness, a golfer with unparalleled skill, and a lover of life's simple pleasures.
​
Friend Like No Other
Logan's kindness was his hallmark. As the greatest friend, he had an innate ability to uplift those around him. His warm and genuine nature created a lasting impact on everyone fortunate enough to be part of his circle.
​
A Golfer Extraordinaire
On the golf course, Logan was unmatched. His swing, described as nothing short of exceptional, left an indelible mark on the sport he loved. A true aficionado, he found joy in the precision of the game and the camaraderie shared with friends.
​
Passions That Defined Him
Logan's love for food, golfing, and UCF football was unparalleled. A self-proclaimed "foodie," he savored the culinary delights that life had to offer. Whether he was teeing off on the golf course or cheering(perhaps wagering) for UCF on game day, Logan embraced his passions with unmatched enthusiasm.
​
The Laid-Back Connoisseur
Known for his laid-back demeanor, Logan navigated life with a calm grace that endeared him to all. His exceptional skills on the golf course were complemented by moments of pure relaxation—kicking back with his loyal dog Reagan, savoring a cold beer, and enjoying the simplicity of life.
​
In Loving Memory
Logan's life may have been cut short, but his legacy lives on through the memories he created and the hearts he touched. This charity event stands as a tribute to the man who brought joy, kindness, and excellence to every aspect of his life.
In honoring Logan's legacy, we strive to continue his legacy of kindness and passion. Join us as we create a positive impact in the world, just as Logan did in the lives of those who were fortunate enough to know him.
T Cell Lymphoma
Understanding Lymphoma: B-cell vs. T-cell
Lymphomas are broadly categorized into Hodgkin and non-Hodgkin lymphomas, with the latter further divided into B-cell and T-cell lymphomas. B-cell lymphomas, being more prevalent, benefit from extensive research and numerous treatment options. However, the same cannot be said for T-cell lymphomas, a group of aggressive diseases with limited funding and therapeutic advancements.​
The Unseen Struggle of T-Cell Lymphomas
While B-cell lymphomas have witnessed significant progress, T-cell lymphomas, particularly the deadly manifestations, remain a formidable challenge. With a myriad of subtypes, research efforts are slow, and treatment options are scarce. Among the rare but highly lethal cases is the spread of T-cell lymphomas to the neurologic system, a devastating complication with limited therapeutic avenues.​
Challenges We Face
Several factors hinder the progress in T-cell lymphoma research. The vast array of T-cell lymphoma types, coupled with the scarcity of cases globally, presents a unique challenge. Moreover, inadequate funding opportunities have impeded substantive and innovative breakthroughs. It is time to confront these challenges head-on and pave the way for a brighter future.
​Transforming Lives Affected by T-Cell Lymphomas
​
​Representation and Equity: We strive to enhance representation from minority populations within T-cell lymphoma research. By addressing relevant questions, we aim to reduce disparities in care and ensure that every patient, irrespective of their background, receives the attention and resources they deserve.​
Research Funds for Understanding Biology: We are committed to providing essential research funds to develop studies that delve into the intricate biology of T-cell lymphomas. Our focus extends beyond the disease itself, exploring the roles of environmental, lifestyle, and cultural factors in shaping variations in T-cell lymphoma incidences across diverse populations.​
Engaging the Research Community: Collaboration is the cornerstone of progress. We actively engage with the research community to bring cutting-edge tools and methodologies to the forefront. By fostering collaboration and innovation, we strive to improve therapies and outcomes for T-cell lymphoma patients—a population with a high unmet need.
